Estimating the public economic consequences of introducing varenicline smoking cessation therapy in South Korea using a fiscal analytic framework-Reference-Cited by-同舟云学术

Estimating the public economic consequences of introducing varenicline smoking cessation therapy in South Korea using a fiscal analytic framework

Published:2018-02-13 Issue:6 Volume:21 Page:571-576
ISSN:1369-6998
Container-title:Journal of Medical Economics
language:en
Short-container-title:Journal of Medical Economics

Author:

Connolly Mark P.¹²,Baker Christine L.³,Kotsopoulos Nikolaos²⁴

Affiliation:

1. Unit of PharmacoEpidemiology & PharmacoEconomics, Department of Pharmacy, University of Groningen, The Netherlands;

2. Global Market Access Solutions, St-Prex, Switzerland;

3. Patient & Health Impact, Pfizer, Inc., New York, NY, USA;

4. Department of Economics, University of Athens, Athens, Greece

Publisher

Informa UK Limited

Subject

Health Policy

Link

https://www.tandfonline.com/doi/pdf/10.1080/13696998.2018.1434183

Reference29 articles.

1. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015. Lancet 2017;389:1885–1906

2. Smoking prevalence and attributable disease burden in 195 countries and territories, 1990–2015: a systematic analysis from the Global Burden of Disease Study 2015

3. The Economic Impact of Smoking and of Reducing Smoking Prevalence: Review of Evidence

4. Health and Economic Burden of Major Cancers Due to Smoking in Korea

5. Economic burden of smoking in Korea

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Estimating the fiscal impact of rare diseases using a public economic framework: a case study applied to hereditary transthyretin-mediated (hATTR) amyloidosis;Orphanet Journal of Rare Diseases;2019-09-18